National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1416256

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1416256
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Pruritus, Rash

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Diagnostic Lab Data:
CDC 'Split Type': JPPFIZER INC2021663137

Write-up: Itching on both forearms; Skin eruption on both forearms; This is a spontaneous report from a contactable physician received via COVID-19 Vaccine Adverse Event Self-Reporting Solution (COVAES). The patient was a 27-year-old male. The most recent COVID-19 vaccine was administered in hospital. The patient didn''t receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medical history. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13May2021 at 02:30PM, the patient previously received the first single dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number EW4811, Expiration date 31Jul2021) intramuscular at left arm for COVID-19 immunization. On 03Jun2021 at 03:00PM (the day of vaccination), the patient received the second single dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number: EY0779, Expiration Date: 31Aug2021) intramuscular at left arm for COVID-19 immunization. On 03Jun2021 at 03:30PM (30 minutes after the vaccination), the patient experienced Itching and Skin eruption on both forearms. The outcome of the event was recovered with treatment including injection of Solu-Medrol 125, Gaster 20, NEORESTAR 10, Sodium Chloride 50ml. Since the vaccination, the patient hasn''t been tested for COVID-19. The reporter started the events result in professional office or clinic visit.; Sender''s Comments: Based on temporal association, the causal relationship between BNT162B2 and the events pruritus and rash cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166